TY - JOUR AU - Yendamuri, S. AU - Caty, L. AU - Pine, M. AU - Adem, S. AU - Bogner, P. AU - Miller, A. PY - 2012 DA - 2012// TI - Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis JO - Surgery. VL - 152 UR - https://doi.org/10.1016/j.surg.2012.05.007 DO - 10.1016/j.surg.2012.05.007 ID - Yendamuri2012 ER - TY - JOUR AU - Travis, W. D. AU - Brambilla, E. AU - Nicholson, A. G. AU - Yatabe, Y. AU - Austin, J. H. M. AU - Beasley, M. B. PY - 2015 DA - 2015// TI - The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000630 DO - 10.1097/JTO.0000000000000630 ID - Travis2015 ER - TY - JOUR AU - Vieira, T. AU - Girard, N. AU - Ung, M. AU - Monnet, I. AU - Cazes, A. AU - Bonnette, P. PY - 2013 DA - 2013// TI - Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma JO - J Thorac Oncol VL - 8 UR - https://doi.org/10.1097/01.JTO.0000437008.00554.90 DO - 10.1097/01.JTO.0000437008.00554.90 ID - Vieira2013 ER - TY - JOUR AU - Ung, M. AU - Rouquette, I. AU - Filleron, T. AU - Taillandy, K. AU - Brouchet, L. AU - Bennouna, J. PY - 2016 DA - 2016// TI - Characteristics and clinical outcomes of Sarcomatoid carcinoma of the lung JO - Clin Lung Cancer VL - 17 UR - https://doi.org/10.1016/j.cllc.2016.03.001 DO - 10.1016/j.cllc.2016.03.001 ID - Ung2016 ER - TY - JOUR AU - Velcheti, V. AU - Rimm, D. L. AU - Schalper, K. A. PY - 2013 DA - 2013// TI - Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) JO - J Thorac Oncol VL - 8 UR - https://doi.org/10.1097/JTO.0b013e318292be18 DO - 10.1097/JTO.0b013e318292be18 ID - Velcheti2013 ER - TY - JOUR AU - Vieira, T. AU - Antoine, M. AU - Hamard, C. AU - Fallet, V. AU - Duruisseaux, M. AU - Rabbe, N. PY - 2016 DA - 2016// TI - Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages JO - Lung Cancer VL - 98 UR - https://doi.org/10.1016/j.lungcan.2016.05.013 DO - 10.1016/j.lungcan.2016.05.013 ID - Vieira2016 ER - TY - STD TI - Domblides C, Leroy K, Monnet I, Mazieres J, Barlesi F, Gounant V, et al. Efficacy of immune checkpoint inhibitors in lung Sarcomatoid carcinoma. J Thorac Oncol. 2020. [Epub ahead of print]. ID - ref7 ER - TY - JOUR AU - Antonia, S. J. AU - Villegas, A. AU - Daniel, D. AU - Vicente, D. AU - Murakami, S. AU - Hui, R. PY - 2017 DA - 2017// TI - Durvalumab after Chemoradiotherapy in stage III non-small-cell lung Cancer JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1709937 DO - 10.1056/NEJMoa1709937 ID - Antonia2017 ER - TY - JOUR AU - Antonia, S. J. AU - Villegas, A. AU - Daniel, D. AU - Vicente, D. AU - Murakami, S. AU - Hui, R. PY - 2018 DA - 2018// TI - Overall survival with Durvalumab after Chemoradiotherapy in stage III NSCLC JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMoa1809697 DO - 10.1056/NEJMoa1809697 ID - Antonia2018 ER - TY - JOUR AU - Reck, M. AU - Rodriguez-Abreu, D. AU - Robinson, A. G. AU - Hui, R. AU - Csoszi, T. AU - Fulop, A. PY - 2016 DA - 2016// TI - Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung Cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606774 DO - 10.1056/NEJMoa1606774 ID - Reck2016 ER - TY - STD TI - Duan J, Cui L, Zhao X, Bai H, Cai S, Wang G, et al. Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 inhibitors in patients with Cancer: a systematic review and meta-analysis. JAMA Oncol. 2019;26. [Epub ahead of print]. ID - ref11 ER - TY - JOUR AU - Takamori, S. AU - Takada, K. AU - Toyokawa, G. AU - Azuma, K. AU - Shimokawa, M. AU - Jogo, T. PY - 2018 DA - 2018// TI - PD-L2 expression as a potential predictive biomarker for the response to anti-PD-1 drugs in patients with non-small cell lung Cancer JO - Anticancer Res VL - 38 UR - https://doi.org/10.21873/anticanres.12933 DO - 10.21873/anticanres.12933 ID - Takamori2018 ER - TY - JOUR AU - Kim, S. AU - Kim, M. Y. AU - Koh, J. AU - Go, H. AU - Lee, D. S. AU - Jeon, Y. K. PY - 2015 DA - 2015// TI - Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: comparison of sarcomatous and carcinomatous areas JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.08.013 DO - 10.1016/j.ejca.2015.08.013 ID - Kim2015 ER -